Latest analyst takes
OptionsPlayBULLElevance Health's 2027 Medicare rates came in much better than expected (roughly a 5% blended/risk-adjusted growth equating to about $13), which supports a healthier revenue outlook and recent upside in the stock.23d agoOptionsPlayBULLI view Elevance Health as my top defensive healthcare pick given improving 2027 risk-adjusted Medicare payments and a path to meaningful upside from current levels into the mid-300s.30d ago"Elevance Health's 2027 Medicare rates came in much better than expected (roughly a 5% blended/risk-adjusted growth equating to about $13), which supports a healthier revenue outlook and recent upside in the stock."
"I view Elevance Health as my top defensive healthcare pick given improving 2027 risk-adjusted Medicare payments and a path to meaningful upside from current levels into the mid-300s."